Missed opportunities for human papillomavirus vaccination at office visits during which influenza vaccine was administered: An AAP pediatric research in office settings (PROS) national primary care research network study

Vaccine. 2020 Jul 14;38(33):5105-5108. doi: 10.1016/j.vaccine.2020.05.090. Epub 2020 Jun 12.

Abstract

Introduction: Little is known about missed opportunities (MOs) for HPV vaccination during primary care visits at which influenza vaccination is delivered.

Methods: We extracted electronic health records for HPV vaccine-eligible 11-to-17-year-olds. We assessed the proportion of visits during which an influenza vaccine was given and an HPV vaccine was due, but not given (i.e., MOs).

Results: Of 56,135 eligible visits, 57.5% represented MOs for HPV vaccination. MOs were more common at visits where an initial versus subsequent HPV vaccine dose was due (68.6% vs. 31.3%) and for acute/chronic and nurse-only visits compared to preventive visits (74.0% and 80.2% vs. 36.7%). In a multivariable model, MOs were more likely for the initial HPV dose and for non-preventive visits, but did not vary by patient sex/age.

Conclusions: HPV vaccine MOs were common during visits where influenza vaccine was administered. Increasing simultaneous administration of HPV and influenza vaccines could increase HPV vaccine coverage.

Keywords: Human papillomavirus vaccine; Influenza vaccine; Missed opportunities; Primary care.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alphapapillomavirus*
  • Child
  • Humans
  • Influenza Vaccines*
  • Office Visits
  • Papillomavirus Infections* / prevention & control
  • Papillomavirus Vaccines*
  • Primary Health Care
  • Vaccination

Substances

  • Influenza Vaccines
  • Papillomavirus Vaccines